Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNX-102 SL extension in fibromyalgia
NCT02589275Phase 3Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Aug 2015
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Tonmya in fibromyalgia (FM), sponsored by Tonix Pharmaceuticals. Started Aug 2015; status: completed.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02589275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589275.